Clinical presentations and outcomes of systemic lupus erythematosus patients with infection admitted to the intensive care unit

Lupus

Volumn 22, Issue 7, 2013, Pages 690-696

  Han, B K ^a   Bhatia, R ^a   Traisak, P ^a   Hunter, K ^a   Milcarek, B ^a   Schorr, C ^a   Eid, H ^a   Feinstein, D ^a   Cronin, P ^a   Kolasinski, S L ^a  

^a Cooper Medical School of Rowan University ^*  (United States)

Author keywords

infection; Systemic lupus erythematosus

Indexed keywords

CYCLOPHOSPHAMIDE; HYDROXYCHLOROQUINE; IMMUNOSUPPRESSIVE AGENT; PREDNISONE;

ADULT; APACHE; ARTICLE; BACTERIAL ENDOCARDITIS; BODY TEMPERATURE MEASUREMENT; COLON PERFORATION; COMORBIDITY; CONTROLLED STUDY; DISEASE DURATION; FEMALE; HEART RATE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; INTENSIVE CARE UNIT; LENGTH OF STAY; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MORTALITY; NECROTIZING FASCIITIS; OUTCOME ASSESSMENT; PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; SEPSIS; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTOLIC BLOOD PRESSURE; THROMBOPHLEBITIS; UROSEPSIS;

INFECTION; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; AGED; APACHE; BACTERIAL INFECTIONS; BLOOD PRESSURE; BODY TEMPERATURE; DATABASES, FACTUAL; FEMALE; HEART RATE; HUMANS; INTENSIVE CARE UNITS; LENGTH OF STAY; LEUKOCYTE COUNT; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 84879217747     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203313490240     Document Type: Article

References (28)

1. Grossman JM, Kalunian KC Dubois' lupus erythematosus. 6 th ed. Philadelphia, PA: Lippincott Williams &Wilkins, 2002, pp. 19-31. Wallace DJ Hahn BH, ed. Philadelphia, PA: Lippincott Williams &Wilkins ; 2002: 19-31.
2. Ropes NW Systemic lupus erythematosus. Cambridge, MA: Harvard University Press ; 1976 :
3. Nived O, Sturfelt G, Wolhein F. Systemic lupus erythematosus and infection: A controlled and prospective study including an epidemiologic group. Q J Med. 1985 ; 218: 271-287
4. Lee SL, Wallace SL, Barone R, Blum L, Chase PH. Familial deficiency of two subunits of the first component of complement. C1r and C1s associated with lupus erythematosus-like disease. Arthritis Rheum. 1978 ; 21: 958-967
5. Hyatt AC, Altenburger KN, Johnston RB, Winkelstein JA. Increased susceptibility to severe pyogenic infections in patients with an inherited deficiency of the second component of complement. J Pediatr. 1981 ; 98: 417-419
6. Mascart-Lemone F, Hauptmann G, Goetz J, et al. Genetic deficiency of C4 presenting with recurrent infections and a SLE-like disease. Am J Med. 1983 ; 75: 295-304
7. Perez HD, Andron RI, Goldstein IM. Infection in patients with systemic lupus erythematosus. Association with a serum inhibitor of complement-derived chemotactic activity. Arthritis Rheum. 1979 ; 22: 1326-1333
8. Martínez-Cairo Cueto S, Ramírez-Lacayo ML, Veladiz-Saint-Martin P, López-Román M. Deterioration of intracellular destruction capacity of S. aureus in children with systemic lupus erythematosus [in English and Spanish]. Arch Invest Med (Mex). 1986 ; 17: 25-36
9. Roberts PJ, Isenberg DA, Segal AW. Defective degradation of bacterial DNA by phagocytes from patients with systemic and discoid lupus erythematosus. Clin Exp Immunol. 1987 ; 69: 68-78
10. Staples PJ, Gerding DN, Decker JL, Gordon RS. Incidence of infection in systemic lupus erythematosus. Arthritis Rheum. 1974 ; 17: 110-110
11. Ginzler E, Diamond H, Kaplan D, Weiner M, Schlesinger M, Seleznick M. Computer analysis of factors influencing frequency of infection in systemic lupus erythematosus. Arthritis Rheum. 1978 ; 21: 37-44
12. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982 ; 25: 1271-1277
13. Godeau B, Boudjadja A, Dhainaut JF, et al. Outcome of patients with systemic rheumatic disease admitted to medical intensive care units. Ann Rheum Dis. 1992 ; 51: 627-631
14. Janssen NM, Karnad DR, Guntupalli KK. Rheumatologic diseases in the intensive care unit: Epidemiology, clinical approach, management, and outcome. Crit Care Clin. 2002 ; 18: 729-748
15. Williams FM, Chinn S, Hughes GR, Leach RM. Critical illness in systemic lupus erythematosus and the antiphospholipid syndrome. Ann Rheum Dis. 2002 ; 61: 414-421
16. Namendys-Silva SA, Baltazar-Torres JA, Rivero-Sigarroa E, Fonseca-Lazcano JA, Montiel-López L, Domínguez-Cherit G. Prognostic factors in patients with systemic lupus erythematosus admitted to the intensive care unit. Lupus. 2009 ; 18: 1252-1258
17. Budman DR, Steinberg AD. Hematologic aspects of systemic lupus erythematosus. Current concepts. Ann Intern Med. 1977 ; 86: 220-229
18. Kaplan MJ. Neutrophils in the pathogenesis and manifestations of SLE. Nat Rev Rheumatol. 2011 ; 7: 691-699
19. Garcia-Romo GS, Caielli S, Vega B, et al. Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus. Sci Transl Med. 2011 ; 3: 73ra20-73ra20
20. Feng PH, Lin SM, Yu CT, et al. Inadequate antimicrobial treatment for nosocomial infection is a mortality risk factor for systemic lupus erythematous patients admitted to intensive care unit. Am J Med Sci. 2010 ; 340: 64-68
21. Moreels M, Mélot C, Leeman M. Prognosis of patients with systemic rheumatic diseases admitted to the intensive care unit. Intensive Care Med. 2005 ; 31: 591-593
22. Kollef MH, Enzenauer RJ. Predicting outcome from intensive care for patients with rheumatologic diseases. J Rheumatol. 1992 ; 19: 1260-1262
23. Alzeer AH, Al-Arfaj A, Basha SJ, et al. Outcome of patients with systemic lupus erythematosus in intensive care unit. Lupus. 2004 ; 13: 537-542
24. Camargo JF, Tobón GJ, Fonseca N, et al. Autoimmune rheumatic diseases in the intensive care unit: Experience from a tertiary referral hospital and review of the literature. Lupus. 2005 ; 14: 315-320
25. Antón JM, Castro P, Espinosa G, et al. Mortality and long term survival prognostic factors of patients with systemic autoimmune diseases admitted to an intensive care unit: A retrospective study. Clin Exp Rheumatol. 2012 ; 30: 338-344
26. Ansell SM, Bedhesi S, Ruff B, et al. Study of critically ill patients with systemic lupus erythematosus. Crit Care Med. 1996 ; 24: 981-984
27. Ozbalkan Z, Topeli A, Kiraz S, Ozturk MA, Ertenli I, Calguneri M. The contribution of underlying systemic rheumatic diseases to the mortality in patients admitted for intensive care: A matched cohort study. Clin Exp Rheumatol. 2004 ; 22: 223-226
28. The Inserm unit 169 of statistical and epidemiological studies: Factors related to outcome in intensive care: French multicenter study. Crit Care Med. 1989 ; 17: 305-308